Disease

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:39 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

Welcome Renal Warriors

Source Node:
Time Stamp: September 11, 2023 7:57 AM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Source Node:
Time Stamp: November 13, 2022 3:46 AM - Modified On: November 17, 2022 - Published By:
Source Cluster:
Republished By Plato

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that

Netflix Announces Documentary About Quadrigacx’s Downfall

Source Node: https://news.bitcoin.com/netflix-announces-documentary-about-quadrigacxs-downfall/
Time Stamp: September 27, 2021 4:30 AM - Modified On: September 27, 2021 - Published By:
Source Cluster:
Republished By Plato

Netflix, the world’s largest video streaming company, has announced it is working on a documentary that deals with the aftermath of the Quadrigacx saga. According to brief descriptions, the documentary titled; “Trust No One: The Hunt for the Crypto King,” deals with how the users affected by the death of Quadrigacx’s CEO Gerry Cotten try to uncover the mystery behind his strange death and the private keys that supposedly only he held at his death. Netflix To Release Quadrigacx Documentary Next Year Netflix, one of the leading video streaming sites,

Netflix will premier life of QuadrigaCX CEO next year 

Source Node: https://bitcoinerx.com/blockchain/netflix-will-premier-life-of-quadrigacx-ceo-next-year/
Time Stamp: September 26, 2021 3:48 AM - Modified On: September 26, 2021 - Published By:
Source Cluster:
Republished By Plato

Netflix, the world-renowned online streaming service, is preparing to release a documentary that revolves around the death of Gerland Cotten.  Cotten is the founder and chief executive officer of QuadrigaCX, a now-defunct Canadian crypto exchange.  “Trust no One: The Hunt for the Crypto King”, will be the title of the upcoming documentary, which was announced by the streaming giant on Twitter.  Suspicious death In the synopsis provided by Netflix, the documentary will chronicle a group of QuadrigaCX investors who have turned into investigators. These people want to know the truth

A Courageous Child Stood up for Girls’ Education and Is Changing the World Malala Yousafzai’s Heroic Story Comes to Life at The Children’s Museum of Indianapolis

Source Node: https://www.prweb.com/releases/a_courageous_child_stood_up_for_girls_education_and_is_changing_the_world_malala_yousafzais_heroic_story_comes_to_life_at_the_childrens_museum_of_indianapolis/prweb18172650.htm
Time Stamp: September 19, 2021 4:00 AM - Modified On: September 19, 2021 - Published By:
Source Cluster:
Republished By Plato

Malala talk to families about the power of education I hope people come here and see this exhibit and see how one family, with great values of equality, justice, love, respect and empathy can change their lives at home and can also change their communities and their countries as well. - Ziauddin Yousafzai/Malala's Father INDIANAPOLIS (PRWEB) September 19, 2021 The youngest Nobel Peace Prize recipient dared to stand up to the Taliban in a fight for education and equal rights and now serves as inspiration to others in The Power

New Lab Studies Suggest InBios COVID-19 POC Antigen Detection Test Will Detect Delta Variant

Source Node: https://www.prweb.com/releases/new_lab_studies_suggest_inbios_covid_19_poc_antigen_detection_test_will_detect_delta_variant/prweb18146251.htm
Time Stamp: August 22, 2021 9:00 AM - Modified On: August 22, 2021 - Published By:
Source Cluster:
Republished By Plato

SCoV-2 Ag Detect Rapid Test SEATTLE (PRWEB) August 22, 2021 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that laboratory studies suggest its SCoV-2 Ag Detect Rapid Test will detect the Delta variant (lineage B.1.617.2), which is responsible for a rapid rise of infections and deaths in the US and around the world. Initial studies suggest that InBios’ point-of-care antigen test will detect the Delta variant at rates similar to the USA-WA1-2020 isolate that was used to develop the assay. “Having a rapid

USPTO Issues Patent for ElectroClave™ UV-C Disinfection System

Source Node: https://www.prweb.com/releases/uspto_issues_patent_for_electroclave_uv_c_disinfection_system/prweb18120314.htm
Time Stamp: August 10, 2021 10:10 AM - Modified On: August 10, 2021 - Published By:
Source Cluster:
Republished By Plato

ORLANDO, Fla. (PRWEB) August 10, 2021 Seal Shield, LLC today announced the issuance of US Utility Patent No.: US 11,058,783 B2 for the ElectroClave™ “UV Sterilization System and Device and Related Methods.” Seal Shield’s ElectroClave™ UV-C Mobile Device Disinfection system has been validated as a unique, novel method to effectively reduce 99.9% of the “Superbug” MRSA, as well as other dangerous pathogens including VRE, MRSA, CRE, S. aureus and E.coli on hard, non-porous surfaces, such as cell phones and tablets. Methicillin-resistant Staphylococcus aureus (MRSA), commonly known as the “Superbug,” is

The Effect of Coronavirus on the Cryptocurrency Market

Source Node: https://coinrabbit.io/blog/the-effect-of-coronavirus-on-the-cryptocurrency-market/
Time Stamp: December 30, 2020 5:58 AM - Modified On: May 21, 2021 - Published By:
Source Cluster:
Republished By Plato

The year 2020, has been greatly eventful. From threats of a world war, to increased terrorist attacks. A biography on the life of the year 2020, would not only be a bestseller but also an excellent read. However the most significant single event of this year is and has been the coronavirus (COVID-19) pandemic, at its global takeover. From a regular virus, one that was once considered to be not worse than a cold flu, to transition into a global pandemic outbreak. The COVID-19 pandemic has affected every aspect of